Fast Growth in Real and “Virtual” Biobanks May be Revenue Opportunity for Clinical Pathology Laboratories

Biobanking is now a $7.9 billion industry and demand for specimens is skyrocketing Biobanking is going big time! VisionGain estimates that biobanking is now a $7.9 billion industry. That’s a revenue number that should interest pathologists and clinical laboratory managers, since their organizations access large volumes of patient specimens every year. As one source of human specimens, both clinical laboratories and anatomic pathology groups have an opportunity to participate in biobanking...

Sequencing Developers’ Unprecedented Success Drives More Ambitious Goals For Genomics X Prize

New Genomic X PRIZE goals/subjects accelerate the drive toward personalized medicine Swift improvements to the accuracy, speed, and lower cost of rapid gene sequencing have caused the sponsors of the globally-known X PRIZE to revamp their offer of a $10 million award to a team that is first to achieve a defined milestone in whole human genome sequencing. Pathologists and clinical laboratory managers will be interested to learn how, last month, the X PRIZE Foundation announced a number of major...